Shareholder's Equity - Additional information (Details) - EUR (€) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Nov. 14, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Shareholder's Equity | |||||
| Exercise price for SPAs exercised | € 1 | € 1 | |||
| Shares issued in relation to share based compensation | 225,451 | ||||
| Treasury shares repurchased | 290,000 | ||||
| Purchase of treasury shares | € 1,548,000 | € 1,548,000 | |||
| Average cost per acquired share | € 5.34 | ||||
| Shares available to issue | 47,337,852 | ||||
| Additional capital authorised | € 35,434,147 | ||||
| Number of shares in entity held by entity or by its subsidiaries or associates | 319,507 | 167,415 | 250,000 | 250,000 | |
| Proportion of treasury shares to total share capital | 0.20% | 0.10% | |||
| Share Performance Plans and Stock Option Plans | |||||
| Shareholder's Equity | |||||
| Shares available to issue | 11,947,322 | ||||
| Holders or creditors of convertible bonds and/or bonds with warrants, profit participation rights and/or income bonds | |||||
| Shareholder's Equity | |||||
| Shares available to issue | 35,390,530 | ||||